Building a Long-Term Model for Patient Access in the UAE

Situation In the early 2010s, the United Arab Emirates (UAE) was investing heavily in healthcare, yet affordability remained a barrier for some patients seeking access to high quality treatments. Age related macular degeneration (AMD) and multiple sclerosis (MS) were two examples where effective therapies were available, but the cost of sustained treatment could put them … Continued

Overcoming Treatment Adherence Barriers

Situation For patients living with chronic conditions, starting treatment is only the beginning. Staying on treatment over the long term can be influenced by a range of factors, from the demands of the therapy itself to a patient’s circumstances, support network, healthcare experience, and ability to manage their condition day to day. The challenge is … Continued

Bridging the Gap Between Market Entry and Reimbursement in the GCC

Situation A multinational pharmaceutical company with an oncology portfolio wanted to understand whether, and how, to bring its products to market across the Gulf Cooperation Council (GCC). The company knew that a traditional commercial route wouldn’t work due to affordability and reimbursement barriers to the products. They needed a clear picture of market feasibility and … Continued

CEO Dr. Joseph Saba recognized among Forbes Middle East’s Top Healthcare Leaders 2025

The recognition highlights Axios’ leadership contributing to the evolution of healthcare across the Middle East. The recognition highlights Axios’ leadership contributing to the evolution of healthcare across the Middle East. It comes at a time when regional health systems are increasingly focused on innovation, sustainability, digital transformation and improving patient outcomes. The recognition reflects a … Continued